Byondis' breast cancer drug fails to bloom as FDA denies approval

Byondis' breast cancer drug fails to bloom as FDA denies approval

Submitted by admin on May 16, 2023 - 10:27pm
Source: 
Fierce Biotech
News Tags: 
Byondis
antibody-drug conjugate
FDA
breast cancer
HER-2 positive breast cancer
Headline: 
Byondis' breast cancer drug fails to bloom as FDA denies approval
snippet: 

Byondis' efforts to get an antibody-drug conjugate (ADC) treatment for HER-2 positive metastatic breast cancer have been pruned by the FDA.

Do Not Allow Advertisers to Use My Personal information